These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9369994)

  • 41. Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agents.
    Clark WM; Lutsep HL
    Neuroimaging Clin N Am; 1999 Aug; 9(3):465-73. PubMed ID: 10433639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Ford G; Freemantle N
    Lancet; 1999 Jan; 353(9146):65; author reply 67-8. PubMed ID: 10023968
    [No Abstract]   [Full Text] [Related]  

  • 43. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Raha S
    Lancet; 1999 Jan; 353(9146):66; author reply 67-8. PubMed ID: 10023970
    [No Abstract]   [Full Text] [Related]  

  • 44. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Lees KR
    Lancet; 1999 Jan; 353(9146):65-6; author reply 67-8. PubMed ID: 10023969
    [No Abstract]   [Full Text] [Related]  

  • 45. Administration of recombinant tissue plasminogen activator to a case of cerebral infarction in the setting of painless aortic dissection.
    Takeuchi S; Takasato Y; Masaoka H; Otani N
    Neurol India; 2009; 57(6):808-9. PubMed ID: 20139520
    [No Abstract]   [Full Text] [Related]  

  • 46. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pleiotropic effects of tissue plasminogen activator].
    Itoh Y
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():589-96. PubMed ID: 17465065
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thrombolytics and neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident].
    Yepes MS
    Rev Neurol; 2001 Feb 1-15; 32(3):259-66. PubMed ID: 11310282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of nimodipine on final infarct volume after acute ischemic stroke.
    Fogelholm R; Erilä T; Palomäki H; Murros K; Kaste M
    Cerebrovasc Dis; 2000; 10(3):189-93. PubMed ID: 10773644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.
    Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J
    Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ECASS II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Barer D
    Lancet; 1999 Jan; 353(9146):66-7; author reply 67-8. PubMed ID: 10023971
    [No Abstract]   [Full Text] [Related]  

  • 53. [Microcirculatory, hemorheologic and microcirculatory parameters before and following hypervolemic hemodilution in patients with acute cerebrovascular disorders].
    Staedt U; Kortsik C; Seufzer U; Lessenich A; Hütt M; Keller H
    Vasa Suppl; 1989; 27():33-4. PubMed ID: 2482989
    [No Abstract]   [Full Text] [Related]  

  • 54. Stroke. Damage control.
    Gorman C
    Time; 1996; 148(14):30-2, 35. PubMed ID: 10172748
    [No Abstract]   [Full Text] [Related]  

  • 55. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Jenkinson D
    Lancet; 1999 Jan; 353(9146):67-8. PubMed ID: 10023972
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent advances in stroke therapy.
    Zivin JA
    West J Med; 1998 Apr; 168(4):261-2. PubMed ID: 9584664
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonstroke treatment.
    Landau WM
    Arch Neurol; 2006 Oct; 63(10):1506; author reply 1506-7. PubMed ID: 17030674
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute ischemic stroke treatment in 2007.
    Goldstein LB
    Circulation; 2007 Sep; 116(13):1504-14. PubMed ID: 17893286
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical effect of mechanical fragmentation combined with recombinant tissue plasminogen activator artery thrombolysis on acute cerebral infarction.
    Jia XF; Hong Z; Fan JH; Zhang YM
    J Biol Regul Homeost Agents; 2016; 30(3):821-826. PubMed ID: 27655505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.